Peer-influenced content. Sources you trust. No registration required. This is HCN.

Northwestern MedicineThe protein FOXK2 — a little-known transcription factor previously studied in the context of metabolism — promotes survival of cancer stem cells in ovarian cancer

Blocking expression of FOXK2 in cancer stem cells inhibited growth of these cells, reducing their so-called “stemness,” making them more like normal cells.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form